Cantitate/Preț
Produs

Barrett’s Esophagus: Emerging Evidence for Improved Clinical Practice

Autor Douglas Pleskow, Tolga Erim
en Limba Engleză Paperback – 29 mar 2016
Barrett’s Esophagus: Emerging Evidence for Improved Clinical Practice is a comprehensive reference on the treatment and new imaging modalities of Barrett’s Esophagus for researchers, clinicians, and scholars. Each chapter is composed from the perspective of investigators who summarize the data as well as the reasoning behind why those studies were conceived.
In addition, the future directions of research are discussed within each chapter, providing insights from the investigators. Research questions are described, and cutting-edge applications are explained. Each chapter contains clinical scenarios to highlight the directions in which the research is, and should be, heading.


  • Provides a perspective into the research behind Barrett’s Esophagus
  • Emphasizes the emerging technologies in surveillance and treatment of Barrett’s
  • Features clinical scenarios to highlight the directions in which research is, and should be, heading
  • Includes coverage of current guidelines and discussions on where these guidelines fall short
Citește tot Restrânge

Preț: 61360 lei

Preț vechi: 88713 lei
-31%

Puncte Express: 920

Carte tipărită la comandă

Livrare economică 12-26 octombrie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.

Specificații

ISBN-13: 9780128025116
ISBN-10: 0128025115
Pagini: 234
Dimensiuni: 191 x 235 x 13 mm
Greutate: 0.5 kg
Editura: ELSEVIER SCIENCE

Public țintă

Gastroenterology Researchers and Gastroenterologists.

Cuprins

Chapter 1. A disease entity is identifiedChapter 2. Fluctuating risk factors and epidemiologyChapter 3. Metaplasia and dysplasia in Barrett’s esophagusChapter 4. Genetics of Barrett’s and Esophageal Adenocarcinoma: implications for prevention, diagnosis and treatment Chapter 5. Biomarkers in Barrett’s and Esophageal AdenocarcinomaChapter 6. Diagnosis of Barrett’s esophagusChapter 7. Screening and surveillance of Barrett’s esophagusChapter 8. Enhanced Imaging of the Esophagus: Spectroscopy Chapter 9. Enhanced Imaging of the Esophagus : Optical Coherence Tomography Chapter 10. Enhanced Imaging of the Esophagus : Confocal Laser Endomicroscopy Chapter 11. History of ablative therapies for Barrett’s and superficial adenocarcinoma Chapter 12. Radiofrequency ablation Chapter 13. Cryospray ablationChapter 14. Endoscopic surgical therapiesChapter 15. Chemoprevention of Barrett’s and AdenocarcinomaChapter 16. Post treatment surveillance, risk for recurrence of Barrett’s and adenocarcinoma after treatment

Notă biografică

Dr. Pleskow's major research interests have been the study of serologic markers in pancreatic disease, therapeutic pancreaticobiliary endoscopy and endoscopic ultrasound. He pioneered the endoscopic placement of gold markers in patients with pancreaticobiliary malignancy to facilitate Cyberknife therapy. He and his colleagues have worked closely on the endoscopic treatment of Gastroesophageal Reflux Disease (GERD) and Barrett's esophagus. Dr. Pleskow is also an active and influential member of the NPF (National Pancreas Foundation) board and its Executive Committee. He has also previously served as Executive Director and currently presides over the Scientific Advisory Committee and sits on the Grant Review Council. Dr. Pleskow holds board certification from the American Board of Internal Medicine (Gastroenterology).